Clinical Trial Update: Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma

View source ↗

Summary

The clinical trial examining marrow and blood changes in glioblastoma patients is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Duke University | Conditions: Glioblastoma | Status: SUSPENDED